Media.Player

RAD51C

總結

RAD51C as a novel susceptibility gene for hereditary breast and ovarian cancer.

技術優勢

RAD51C as a novel susceptibility gene for hereditary: breast cancer, ovarian cancer, head and neck squamous cell carcinomas (HNSCC).
RAD51C as companion diagnostic for PARP or TOPO I Inhibitors.

技術應用

Professional societies and health care systems, risk-adapted personalized treatment, identify individuals with germline and/or somatic mutation(s) in cancer risk genes

詳細技術說明

A novel susceptibility gene for hereditary cancers. RAD51C, which encodes for a protein involved in DNA repair, has been found to be mutated in families with breast and ovarian cancer, but not in healthy control subjects

合作類型

Licensing

申請日期

09/04/2010 00:00:00

申請號碼

EP20100159524 20100409

分類

- international:
C12Q1/68
- cooperative:
C12Q1/6886; C12Q2600/106; C12Q2600/156

其他

Patent application

ID號碼

2301

國家/地區

德國